State Street’s Bioverativ Inc. Common Stock BIVV Stock Holding History

State Street’s Portfolio BIVV Stock Details BIVV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-4,306,019	Closed	-$232M	–	3815
2017 Q4	$232M	Sell	4,306,019 -134,509	-3%	-$7.36M	0.02%	633
2017 Q3	$253M	Buy	4,440,528 +270,239	+6%	+$15.8M	0.02%	598
2017 Q2	$251M	Sell	4,170,289 -17,744	-0.4%	-$1.01M	0.02%	592
2017 Q1	$228M	Buy	+4,188,033	New	+$206M	0.02%	622

Other funds holding BIVV

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

ACS

Archford Capital Strategies Swansea, Illinois $987M AUM 29.31% 1-Year Est. Return

State Street's BIVV Position: Q1 2018 in Review

State Street sold out of Bioverativ Inc. Common Stock (BIVV) in Q1 2018, closing a stake of 4,306,019 shares — an estimated $232M sold.

State Street first reported a position in BIVV in Q1 2017 and held it in 4 quarters. The position peaked at $253M in Q3 2017. 2 funds tracked by Wall St. Rank hold BIVV as of Q1 2018.

State Street reported no remaining Bioverativ Inc. Common Stock position as of Q1 2018 after selling out during the quarter.
State Street sold 4,306,019 Bioverativ Inc. Common Stock shares in Q1 2018, an estimated $232M.
State Street first reported a position in Bioverativ Inc. Common Stock in Q1 2017 and held it in 4 quarters.
State Street's Bioverativ Inc. Common Stock position peaked at $253M in Q3 2017.
2 funds tracked by Wall St. Rank held Bioverativ Inc. Common Stock as of Q1 2018.

Based on State Street's 13F filing for Q1 2018, filed 15 May 2018.